Small biopharma company NanoViricides sees stock soar on coronavirus treatment claims
July 14, 2020 at 07:00 AM EDT
NanoViricides claims it's near clinical trials for a treatment, but a CNBC investigation found it has never tested a product in humans or made any revenue.